Macrophage Markers Market Size is valued at USD 240.64 Million in 2022 and is predicted to reach USD 439.65 Million by the year 2031 at a 7.11% CAGR during the forecast period for 2023-2031.
Macrophage markers are distinct molecules or proteins utilized for identifying and characterising macrophages, a particular type of immune cell responsible for guarding the body against infections and foreign substances. These indicators aid researchers and doctors in differentiating macrophages from other cell types and comprehending their roles in diverse tissues and circumstances. Macrophages commonly studied and isolated for research or diagnostic purposes can be identified using certain cell surface proteins. These proteins, such as CD14, CD68, and CD163, are frequently employed in laboratory procedures like flow cytometry or immunohistochemistry.
The ongoing research in immunology and inflammation fuels the demand for tools and reagents such as macrophage markers. As we get a better understanding of macrophage biology, there is a rising demand for more specific and sensitive markers to characterise macrophage subtypes and roles.
The COVID-19 pandemic has profoundly affected numerous businesses, particularly the life sciences and healthcare sectors. The pandemic caused laboratory operations to be disrupted, including research project delays, academic institution closures, and decreased access to research resources. This slowed the speed of macrophage marker-related research.
The Macrophage Markers Market is segmented on the basis of marker type, application, disease area, and end-use. Based on the marker type, the market is segmented as CD68, CD163, CD206, CD14, CD11b, CD64, CD11c, and Others. The application segment includes Research Use, Diagnostic Use, and Drug Development. According to disease area, the market is segmented into Oncology, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases, Neurological Disorders, and Others. The end-user segment includes Research Institutes and Academic Centers, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, and Others.
The CD68 category is expected to hold a major share in the global Macrophage Markers Market in 2022. Several factors influence the market for CD68 markers, notably in the context of macrophages, and contribute to its growth and development. CD68 is a glycoprotein that is abundant in macrophages and is often employed as a tissue macrophage marker. Immunology and inflammatory research are important drivers of the CD68 markers industry. Because macrophages play an important role in immune response and inflammatory processes, there is a significant demand for markers like CD68 for researching and characterising these cells in various situations.
The personal care segment is estimated to grow at a rapid rate in the global Macrophage Markers Market. Macrophage markers are critical in oncology for understanding the role of macrophages in tumour genesis, progression, and response to treatment. In the tumour microenvironment, macrophages are a prominent component of the immune infiltration. TAMs can have pro- or anti-tumoral effects, and understanding their function is critical for creating targeted cancer therapeutics. The necessity to characterise TAMs in various malignancies drives the desire for macrophage markers. Imaging technology, flow cytometry, and molecular biology approaches have improved the precision and efficiency of macrophage marker analysis.
The North American macrophage Markers Market is expected to record the maximum market revenue share in the near future. The increased frequency of cancer and other chronic diseases, rising demand for cell-based therapeutics, and expanding immunology research efforts are driving the expansion of this market. The demand for macrophage markers is being fueled by ongoing research in immunology, cancer biology, and inflammatory illnesses. Academic institutions, research institutes, and pharmaceutical businesses in North America are currently engaged in studies into the functions of macrophages in different health situations. Furthermore, the Asia Pacific region is estimated to experience significant growth in the worldwide Macrophage Markers Market. Research and development endeavors in several scientific fields have experienced a substantial rise in the Asia Pacific area. The demand for macrophage markers is fueled by the growing investment in life sciences research from universities, research organizations, and pharmaceutical companies.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 240.64 Million |
|
Revenue Forecast In 2031 |
USD 439.65 Million |
|
Growth Rate CAGR |
CAGR of 7.11% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Marker Type, Disease Area, Application, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BD Biosciences, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., BioLegend, Inc., Merck KGaA, Novus Biologicals, LLC, R&D Systems, Inc. (a Bio-Techne brand), Santa Cruz Biotechnology, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, GeneTex, Inc., MBL International Corporation and Others. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Macrophage Marker Market Snapshot
Chapter 4. Global Macrophage Marker Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Marker Type Estimates & Trend Analysis
5.1. By Marker Type, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Marker Type:
5.2.1. CD68
5.2.2. CD163
5.2.3. CD206
5.2.4. CD14
5.2.5. CD11b
5.2.6. CD64
5.2.7. CD11c
5.2.8. Others
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Application:
6.2.1. Research Use
6.2.2. Diagnostic Use
6.2.3. Drug Development
Chapter 7. Market Segmentation 3: By Disease Area Estimates & Trend Analysis
7.1. By Disease Area & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Disease Area:
7.2.1. Oncology
7.2.2. Infectious Diseases
7.2.3. Autoimmune Diseases
7.2.4. Cardiovascular Diseases
7.2.5. Neurological Disorders
7.2.6. Others
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By End User & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By End User:
8.2.1. Research Institutes and Academic Centers
8.2.2. Pharmaceutical and Biotechnology Companies
8.2.3. Clinical and Diagnostic Laboratories
8.2.4. Others
Chapter 9. Macrophage Marker Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Macrophage Marker Market revenue (US$ Million) estimates and forecasts By Marker Type, 2023-2031
9.1.2. North America Macrophage Marker Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
9.1.3. North America Macrophage Marker Market revenue (US$ Million) estimates and forecasts By Disease Area, 2023-2031
9.1.4. North America Macrophage Marker Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
9.1.5. North America Macrophage Marker Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
9.2. Europe
9.2.1. Europe Macrophage Marker Market revenue (US$ Million) By Marker Type, 2023-2031
9.2.2. Europe Macrophage Marker Market revenue (US$ Million) By Application, 2023-2031
9.2.3. Europe Macrophage Marker Market revenue (US$ Million) By Disease Area, 2023-2031
9.2.4. Europe Macrophage Marker Market revenue (US$ Million) By End User, 2023-2031
9.2.5. Europe Macrophage Marker Market revenue (US$ Million) by country, 2023-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Macrophage Marker Market revenue (US$ Million) By Marker Type, 2023-2031
9.3.2. Asia Pacific Macrophage Marker Market revenue (US$ Million) By Application, 2023-2031
9.3.3. Asia Pacific Macrophage Marker Market revenue (US$ Million) By Disease Area, 2023-2031
9.3.4. Asia Pacific Macrophage Marker Market revenue (US$ Million) By End User, 2023-2031
9.3.5. Asia Pacific Macrophage Marker Market revenue (US$ Million) by country, 2023-2031
9.4. Latin America
9.4.1. Latin America Macrophage Marker Market revenue (US$ Million) By Marker Type, (US$ Million) 2023-2031
9.4.2. Latin America Macrophage Marker Market revenue (US$ Million) By Application, (US$ Million) 2023-2031
9.4.3. Latin America Macrophage Marker Market revenue (US$ Million) By Disease Area, (US$ Million) 2023-2031
9.4.4. Latin America Macrophage Marker Market revenue (US$ Million) By End User, (US$ Million) 2023-2031
9.4.5. Latin America Macrophage Marker Market revenue (US$ Million) by country, 2023-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Macrophage Marker Market revenue (US$ Million) By Marker Type, (US$ Million) 2023-2031
9.5.2. Middle East & Africa Macrophage Marker Market revenue (US$ Million) By Application, (US$ Million) 2023-2031
9.5.3. Middle East & Africa Macrophage Marker Market revenue (US$ Million) By Disease Area, (US$ Million) 2023-2031
9.5.4. Middle East & Africa Macrophage Marker Market revenue (US$ Million) By End User, (US$ Million) 2023-2031
9.5.5. Middle East & Africa Macrophage Marker Market revenue (US$ Million) by country, 2023-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Abcam plc,
10.2.2. Bio-Rad Laboratories, Inc.,
10.2.3. Cell Signaling Technology, Inc.,
10.2.4. BD Biosciences,
10.2.5. Thermo Fisher Scientific, Inc.,
10.2.6. Agilent Technologies, Inc.,
10.2.7. BioLegend, Inc.,
10.2.8. Merck KGaA,
10.2.9. Novus Biologicals, LLC,
10.2.10. R&D Systems, Inc. (a Bio-Techne brand),
10.2.11. Santa Cruz Biotechnology, Inc.,
10.2.12. Beckman Coulter, Inc.,
10.2.13. Miltenyi Biotec GmbH,
10.2.14. GeneTex, Inc.,
10.2.15. MBL International Corporation
10.2.16. Others
Macrophage Markers Market By Marker Type-
Macrophage Markers Market By Application-
Macrophage Markers Market By Disease Type-
Macrophage Markers Market By End-User-
Macrophage Markers Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
